Tested Applications
| Positive WB detected in | MCF-7 cells |
| Positive IHC detected in | human breast cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:2000-1:10000 |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
28357-1-AP targets WNK1 in WB, IHC, IF, CoIP, ELISA applications and shows reactivity with Human samples.
| Tested Reactivity | Human |
| Cited Reactivity | human, rat |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag28034 Product name: Recombinant human WNK1 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-209 aa of BC021121 Sequence: MSGGAAEKQSSTPGSLFLSPPAPAPKNGSSSDSSVGEKLGAAAADAVTGRTEEYRRRRHTMDKDSRGAAATTTTTEHRFFRRSVICDSNATALELPGLPLSLPQPSIPAAVPQSAPPEPHREETVTATATSQVAQQPPAAAAPGEQAVAGPAPSTVPSSTSKDRPVSQPSLVGSKEEPPPARSGSGGGSAKEPQEERSQQQDDIEELET Predict reactive species |
| Full Name | WNK lysine deficient protein kinase 1 |
| Calculated Molecular Weight | 251 kDa |
| Observed Molecular Weight | 250-300 kDa |
| GenBank Accession Number | BC021121 |
| Gene Symbol | WNK1 |
| Gene ID (NCBI) | 65125 |
| RRID | AB_2881119 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9H4A3 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for WNK1 antibody 28357-1-AP | Download protocol |
| WB protocol for WNK1 antibody 28357-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The anti-WNK1 antibody (Cat# 28357-1-AP) has 7 total citations published in Cell Death Dis, Eur J Pharmacol, BMC Cancer, Mol Carcinog, Exp Cell Res, Front Oncol, and Endocrine. Research fields span oncology (multiple myeloma, lung cancer, hepatocellular carcinoma, ovarian cancer), ion transport and homeostasis, and cell signaling pathways. Applications include WB, IF, and CoIP in human and rat samples.
| Species | Application | Title |
|---|---|---|
Cell Death Dis Single-cell sequencing analysis of multiple myeloma heterogeneity and identification of new theranostic targets | ||
Eur J Pharmacol Ionic dependency, sensitivity to transport inhibitors and signal transduction of propionate-induced anion secretion in rat caecum. | ||
BMC Cancer Lymphocyte migration regulation related proteins in urine exosomes may serve as a potential biomarker for lung cancer diagnosis | ||
Mol Carcinog Focal adhesion kinase confers lenvatinib resistance in hepatocellular carcinoma via the regulation of lysine-deficient kinase 1
| ||
Exp Cell Res Human adenylate kinase 6 regulates WNK1 (with no lysine kinase-1) phosphorylation states and affects ion homeostasis in NT2 cells. | ||
Front Oncol Development of CSOARG: a single-cell and multi-omics-based machine learning model for ovarian cancer prognosis and drug response prediction |







